ReviewCurrent opinion in toxicology2017

Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design.

Kirsten M Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.